Company intelligence / Profile preview

Rigen Biotech

Shanghai, Shanghai, Chinarigen-bio.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Rigen Biotech develops, manufactures, and sells molecular diagnostic products including qPCR assays, NGS assays, and specialized solutions for thyroid cancer diagnosis such as the Thyroscan® classifier. The company provides full-process solutions from preoperative sampling to postoperative monitoring for thyroid nodules/cancer. No clinical trial results are reported as it is a diagnostics-focused business.

Therapeutic areas: Oncology
Modalities: PCR-based diagnosticsNGS-based diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Rigen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rigen Biotech.

Explore the full profile